Markets:

Overview

News

Currencies

International

Treasuries

CRISPR Therapeutics AG - Common Shares (NQ:CRSP)

48.87 -1.06 (-2.12%)

Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about CRISPR Therapeutics AG - Common Shares

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

35 36 Next >

Ross Stores Reports Strong Earnings, Joins Buckle, Twist Bioscience And Other Big Stocks Moving Higher On Friday ↗

November 17, 2023

U.S. stocks traded mostly lower, with the Dow Jones falling over 20 points on Friday.

Via Benzinga

Topics Stocks

CRISPR Therapeutics Stock Earns 88 RS Rating On U.K. Regulator News ↗

November 17, 2023

CRISPR Therapeutics sees its Relative Strength Rating enter the 80-plus level.

Via Investor's Business Daily

3 Long-Term Growth Stocks Analysts Are Bullish On ↗

November 16, 2023

Here are three long-term growth stocks for your consideration if you’re looking to take a long position in a new name or two.

Via InvestorPlace

3 Cathie Wood You’ll Regret Not Buying Soon: November 2023 ↗

November 16, 2023

Cathie Wood thinks we're out of the woods economically, and these stock picks in her portfolio stand to gain the most in coming months.

Via InvestorPlace

Why Is NIO Stock Down 5% Today? ↗

November 16, 2023

Nio stock is falling on Thursday as investors react to negative news following the summit between Presidents Xi Jinping and Joe Biden.

Via InvestorPlace

Why CRISPR Therapeutics Stock Could Be About to Take Off ↗

November 08, 2023

CRISPR's financial prospects could soon get an upgrade.

Via The Motley Fool

Crispr Surges After Winning The First-Ever Approval For A CRISPR-Based Gene-Editing Drug ↗

November 16, 2023

The drug will sell under the brand name Casgevy in the UK for two blood diseases.

Via Investor's Business Daily

What's Going On With Crispr Therapeutics Stock Thursday? ↗

November 16, 2023

CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Thursday after the company announced regulatory authorization of the first CRISPR/Cas9 gene-

Via Benzinga

Citi Is Souring on Plug Power (PLUG) Stock ↗

November 16, 2023

Plug Power stock is falling on Thursday after the EV charging company's shares were hit with a downgrade and lowered price target from Citi.

Via InvestorPlace

CRISPR Therapeutics (CRSP) Stock Jumps as U.K. Authorizes Gene Therapy ↗

November 16, 2023

CRSP stock is up on U.K. authorization for its gene therapy treatment for sickle cell anemia. CRISPR hopes for FDA authorization next spring.

Via InvestorPlace

UK Approves First Crispr Gene Edited Therapy For Sickle Cell Disease, Beta Thalassemia ↗

November 16, 2023

The U.K.

Via Benzinga

Why Palo Alto Networks Shares Are Trading Lower By Around 5%; Here Are 20 Stocks Moving Premarket ↗

November 16, 2023

Shares of Palo Alto Networks, Inc. (NASDAQ: PANW) fell in pre-market trading after reporting first-quarter results.

Via Benzinga

Can CRISPR Therapeutics Stock Double in 5 Years? Here's What It Would Take. ↗

November 16, 2023

A few things put together could push the stock higher.

Via The Motley Fool

Vertex and CRISPR Therapeutics Announce Authorization of the First CRISPR/Cas9 Gene-Edited Therapy, CASGEVY™ (exagamglogene autotemcel), by the United Kingdom MHRA for the Treatment of Sickle Cell Disease and Transfusion-Dependent Beta Thalassemia

November 16, 2023

From Vertex Pharmaceuticals Incorporated

Via Business Wire

Invest in the Future With These 7 Forever Stocks ↗

November 15, 2023

Forever stocks are usually those predicting future trends. Finding them today means pinning down strong financials and prospects without FOMO.

Via InvestorPlace

3 Biotech Stocks With Key Catalysts Coming in December ↗

November 15, 2023

Some of the most exciting opportunities can be found in biotech stocks, especially if there's a powerful catalyst just around the corner.

Via InvestorPlace

2 Stocks to Buy Hand Over Fist as the S&P 500 Rockets Higher ↗

November 14, 2023

These stocks look reasonably priced today considering their long-term prospects.

Via The Motley Fool

Topics Stocks

What's Going On With CRISPR Therapeutics Stock? ↗

November 13, 2023

CRISPR Therapeutics AG (NASDAQ: CRSP) shares are trading higher Monday after Morgan Stanley maintained the company with an Underweight rating and lowered the price target. What To Know:

Via Benzinga

3 Biotech Stocks That Are Poised to Have Breakthroughs in 2024 ↗

November 12, 2023

Investors should consider these "Goldilocks" biotech stocks to buy as they are poised to get significant boosts next year.

Via InvestorPlace

1 No-Brainer Stock to Buy and Hold for 10 Years ↗

November 11, 2023

This company has been in the news for much of the year.

Via The Motley Fool

3 Growth Stocks to Buy Right Now Without Any Hesitation ↗

November 11, 2023

Investors shouldn't have to deliberate for too long about these great stocks.

Via The Motley Fool

Stock Market Rally Pauses As Yields Rebound; Datadog, Affirm Among Earnings Winners: Weekly Review ↗

November 10, 2023

The major indexes ended long win streaks. Datadog led earnings winners.

Via Investor's Business Daily

3 Biotech Stocks That Are Betting on the Future of Gene Editing ↗

November 09, 2023

These three companies have gene editing therapies in late-stage clinical trials, making them promising biotech stocks to buy right now.

Via InvestorPlace

This Program for a Common Problem May Be Vertex Pharmaceuticals' Ticket to a New Wave of Billion-Dollar Revenues ↗

November 09, 2023

Vertex shares look cheap today considering all the company has to offer.

Via The Motley Fool

3 Biotech Stocks With the Strongest Clinical Pipelines ↗

November 08, 2023

Many industry heavyweights are on the hunt for fresh new ideas -- great news for biotech stocks to buy with strong pipelines.

Via InvestorPlace

CRISPR Therapeutics Stock Earns IBD Stock Rating Upgrade ↗

November 08, 2023

On Wednesday, CRISPR Therapeutics stock had its Relative Strength (RS) Rating upgraded to 85, up from 68 a day earlier.

Via Investor's Business Daily

Why you can make Vertex Pharmaceuticals a buy on any pullback

November 08, 2023

Vertex stock is off its all-time highs after a slight miss on revenue, but the company's robust pipeline gives investors a reason to watch VRTX stock closely

Via MarketBeat

Why CRISPR Therapeutics Stock Crushed the Market Today ↗

November 07, 2023

Investors were cheered by the company's latest earnings release, coupled with operational updates.

Via The Motley Fool

Vertex Slouches After Tech Leader Reports Mixed Results; But Late-Stage Pipeline In Focus ↗

November 07, 2023

The company expects $9.85 billion in full-year sales of its cystic fibrosis treatments.

Via Investor's Business Daily

Cathie Wood's ARK Innovation Just Had Its Best Week Ever Thanks To Roku, These Huge Winners ↗

November 06, 2023

Roku vaulted 50% to become Ark Innovation's top holding.

Via Investor's Business Daily

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

35 36 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.